Does this also mean that RAC itself might now be unable to get ethics approval to run a RC110 trial (not that RAC is planning to do so)?
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?, page-6
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.025(2.11%) |
Mkt cap ! $201.5M | |||
| Open | High | Low | Value | Volume |
| $1.22 | $1.22 | $1.16 | $42.21K | 35.95K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 3717 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 6999 | 1 |
View Market Depth
| Last trade - 11.46am 04/07/2025 (20 minute delay) ? |
| RAC (ASX) Chart |